Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Timing of G-CSF Injection for Effective Autologous Stem Cell Collection

Jeong-Eun Kim, Cheolwon Suh, MD, Yunsuk Choi, Eun Kyoung Kim, Byeong Seok Sohn, Inkeun Park, Dok Hyun Yoon, Changhoon Yoo, Geundoo Jang, Shin Kim, Dae Ho Lee, Sang -We Kim, Jung Shin Lee

Blood (2008) 112 (11): 4439.

https://doi.org/10.1182/blood.V112.11.4439.4439

Published: 2008

Journal Articles

The Role of An Early Interim 18 F-FDG PET/CT for Prediction of Outcomes of Patients with Peripheral T Cell Lymphoma

Yoon Hee Choi, MD, Byung Woog Kang, MD, Hyun Soo Hong, MD, Chul Kim, MD, Geundoo Jang, MD, Sung Sook Lee, MD, Jin Sook Ryu, MD, Jooryung Huh, MD, Dae Ho Lee, MD, Sang We Kim, MD, Jung Shin Lee, MD, Cheolwon Suh, MD

Blood (2008) 112 (11): 5272.

https://doi.org/10.1182/blood.V112.11.5272.5272

Published: 2008

Journal Articles

Initial Cytoreductive Treatment with Thalidomide Plus Bolus Vincristine/Doxorubicin and Reduced Dexamethasone (T-bVAd) Followed by Autologous Stem Cell Transplantation (ASCT) for Multiple Myeloma.

Jae-Cheol Jo, Byung Wook Kang, Sun Jin Sym, Sung Sook Lee, Geundoo Jang, Dae Ho Lee, Sang-We Kim, Cheolwon Suh

Blood (2007) 110 (11): 5094.

https://doi.org/10.1182/blood.V110.11.5094.5094

Published: 2007

Journal Articles

Multicenter Phase II Trial of 90 Y-Ibritumomab Tiuxetan with High-Dose Chemotherapy (Busulfan/Cyclophosphamide/Etoposide) Followed by Autologous Stem Cell Transplantation in Relapsed, Refractoried, or High-Risk B-Cell NHL.

Byung Woog Kang, Jae-Cheol Jo, Shin Kim, Geundoo Jang, Sung Sook Lee, Sun Jin Sym, Jin-Sook Ryu, Won Seog Kim, Sung Soo Yoon, Cheolwon Suh

Blood (2007) 110 (11): 1914.

https://doi.org/10.1182/blood.V110.11.1914.1914

Published: 2007

Journal Articles

A Phase I Trial of Bortezomib Plus CHOP Every 2 Weeks in Patients with Advanced Stage Diffuse Large B-Cell Lymphomas.

Geundoo Jang, MD, Sun-Jin Sym, MD, Shin Kim, Dae Ho Lee, MD, Sang We Kim, MD, Jooryung Huh, MD, Won Seog Kim, MD, Cheolwon Suh, MD

Blood (2007) 110 (11): 4446.

https://doi.org/10.1182/blood.V110.11.4446.4446

Published: 2007

NARROW

Timing of G-CSF Injection for Effective Autologous Stem Cell Collection

The Role of An Early Interim 18 F-FDG PET/CT for Prediction of Outcomes of Patients with Peripheral T Cell Lymphoma

Initial Cytoreductive Treatment with Thalidomide Plus Bolus Vincristine/Doxorubicin and Reduced Dexamethasone (T-bVAd) Followed by Autologous Stem Cell Transplantation (ASCT) for Multiple Myeloma.

Multicenter Phase II Trial of 90 Y-Ibritumomab Tiuxetan with High-Dose Chemotherapy (Busulfan/Cyclophosphamide/Etoposide) Followed by Autologous Stem Cell Transplantation in Relapsed, Refractoried, or High-Risk B-Cell NHL.

A Phase I Trial of Bortezomib Plus CHOP Every 2 Weeks in Patients with Advanced Stage Diffuse Large B-Cell Lymphomas.

Email alerts

ASH Publications

American Society of Hematology

Timing of G-CSF Injection for Effective Autologous Stem Cell Collection

The Role of An Early Interim 18 F-FDG PET/CT for Prediction of Outcomes of Patients with Peripheral T Cell Lymphoma

Initial Cytoreductive Treatment with Thalidomide Plus Bolus Vincristine/Doxorubicin and Reduced Dexamethasone (T-bVAd) Followed by Autologous Stem Cell Transplantation (ASCT) for Multiple Myeloma.

Multicenter Phase II Trial of 90 Y-Ibritumomab Tiuxetan with High-Dose Chemotherapy (Busulfan/Cyclophosphamide/Etoposide) Followed by Autologous Stem Cell Transplantation in Relapsed, Refractoried, or High-Risk B-Cell NHL.

A Phase I Trial of Bortezomib Plus CHOP Every 2 Weeks in Patients with Advanced Stage Diffuse Large B-Cell Lymphomas.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only